A chromene-type compound, daedalin A (1), was isolated from mycelial culture broth of Daedalea dickinsii. Based on spectroscopic data, the structure of 1 was found to be (2R)-6-hydroxy-2-hydroxymethyl-2-methyl-2H-chromene. Daedalin A (1) strongly inhibited the activity of tyrosinase (IC 50 : 194 M). In addition, 1 also showed 1,1-diphenyl-2-picrylhydrazyl scavenging activity (IC 50 : 16.9 M) and superoxide anion scavenging activity (IC 50 : 28.5 M).
Dermal hyper-pigmentation, caused by the accumulation of melanin, is initiated by oxidation of tyrosine by tyrosinase, a key enzyme of melanin biosynthesis. 1) Tyrosinase inhibitors such as arbutin, kojic acid, ellagic acid, and rucinol have been used as pharmaceutical constituents of cosmetics in order to prevent hyperpigmentation. In an effort to find new types of tyrosinase inhibitors, we screened culture broths from mushroom mycelia for tyrosinase inhibitory activity, and found that the mycelial culture broth of Daedalea dickinsii showed significant activity. Several bioactive lanostane triterpenes, a collagenase inhibitor, 2) antibiotics, 3) and cytotoxic compounds, 4) were isolated from the fruiting body of D. dickinsii. Bioassay-guided fractionation from the mycelial culture of D. dickinsii led to isolation of a chromene derivative tyrosinase inhibitor, daedalin A (1) . In the present paper we describe the structure and biological activity of 1.
Negative high-resolution FABMS of 1 showed a quasi-molecular ion peak at m=z 191.0712 ½M À H À , indicating the molecular formula C 11 H 12 O 3 . IR showed absorption bands at 3389 cm À1 and 816 cm À1 , suggesting the presence of a hydroxyl group and a benzene ring respectively. The 13 C-NMR spectrum of 1 indicated the presence of four double bonds. Furthermore, the 1 H-NMR spectrum of 1 indicated the presence of three olefinic protons at H 6.67 (d, J ¼ 8:6 Hz), H 6.60 (dd, J ¼ 2:9 Hz, 8.6 Hz), and H 6.50 (d, J ¼ 2:9 Hz), ascribable to a 1,2,4-trisubstituted benzene moiety. The spectrum also showed two olefinic protons coupled with each other at H 6.38 (d, J ¼ 9:9 Hz) and at H 5.61 (d, J ¼ 9:9 Hz), along with a methyl proton at H 1.35 (s) and hydroxyl methyl protons at H 3.59 and H 3.68 (AB quartet, J ¼ 11: 6 Hz) . CH correlations from the HMBC spectrum of 1 were found between an oxygenbearing quaternary carbon ( C 79.0) and an olefin proton ( H 5.61), methyl protons ( H 1.35), and hydroxymethyl protons ( H 3.59 and H 3.68). These CH correlations allowed partial deduction of a 2-oxy-2-hydroxymethyl-3-butene moiety. The six double bond equivalents required by the molecular formula indicated that the compound consisted of a ring, along with a benzene ring and a double bond. CH correlations from HMBC were found between C-8a and H-4, C-8a and H-5, and C-4a and H-3. These observations indicate that the planar structure of 1 was 6-hydroxy-2-hydroxymethyl-2-methyl-2H-chromene, as shown in Fig. 1 .
In synthetic studies of chromene analogs, Goujon et al. synthesized a racemic mixture of 6-hydroxy-2-hydroxymethyl-2-methyl-2H-chromene and one of the enantiomers, (2S)-(À)-6-hydroxy-2-hydroxymethyl-2-methyl-2H-chromene (½ D 20 À7:6 (35% ee). 5, 6) suggesting the (2R)-configuration. To determine the absolute configuration at the C-2 position of 1, we used the phenylglycine methyl ester (PGME) method described by Yabuuchi and Kusumi 7) (Fig. 2) . The phenoxy group of 1 was protected in a form of the methyl ether (2), which was hydrogenated with palladium-carbon to give the 3,4-dihydro derivative (3). After the primary alcohol was oxidized with sulfur trioxide-pyridine complex, it was oxidized with a suspension of silveroxide and sodium hydroxide to give the carboxylic acid (4). Then 4 was condensed with (S)-and (R)-PGME to give (S)-amide (5) and (R)-amide (6) respectively. In the case of -oxygenated chiral carboamide, amides take a conformation in which -oxygen, NH of amide, and ester carbonyl hold syn form on the PGME plane.
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, of H 3 -10 had a negative value, and those of H 2 -3 and H 2 -4 had positive values. The Á value distribution revealed that the stereochemistry of the C-2 position of 1 was R.
Daedalin A (1) showed antioxidant as well as tyrosinase inhibitory activity. Daedalin A (1) dosedependently inhibited tyrosinase from 50 mM to 400 mM; its IC 50 value was 194 AE 7 mM (n ¼ 3). It was approximately three times more potent than arbutin (IC 50 : 672 AE 20 mM, n ¼ 3), which was used as a positive control. We evaluated the 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging activity of 1. Daedalin A (1) scavenged DPPH radicals with an IC 50 value of 16:9 AE 0:5 mM (n ¼ 3), which is comparable to that of trolox (IC 50 : 13:9 AE 0:1 mM, n ¼ 3), commonly used as a positive control in antioxidant tests such as the DPPH radical scavenging test. Furthermore, 1 scavenged superoxide anion, an active form of oxygen generated in vivo, with an IC 50 value of 28:5 AE 0:7 mM (n ¼ 3). The superoxide anion radical scavenging activity of 1 was about 10 times higher than that of trolox (IC 50 : 274 AE 10 mM, n ¼ 3).
We isolated optically active (2R)-6-hydroxy-2-hydroxymethyl-2-methyl-2H-chromene, daedalin A (1), from the mycelial culture broth of D. dickinsii, and found that daedalin A showed both tyrosinase inhibitory and antioxidant activities. Hence daedalin A has the attributes of a model compound for treating dermal hyper-pigmentation. Assay for tyrosinase inhibitory activity. The tyrosinase inhibitory test was performed as previously described, 8) with slight modifications. An L-tyrosine solution (400 ml of 5mM) and 1390 ml of 50mM phosphoric acid buffer solution (pH 6.8) were mixed with 200 ml of sample solution in dimethyl sulfoxide. After the addition of 10 ml of an aqueous solution of mushroom tyrosinase (1000 U/ml, Sigma Chemical, St. Louis, MO), the mixture was incubated at 37 C for 60 min, and then the absorbance at 475 nm was measured to estimate the activity. Tyrosinase inhibition was calculated as inhibition (%) = 100 Â (A À B)/A, where A represents the absorbance of the control, and B represents the difference in absorbance before and after incubation of the test sample.
Assay for DPPH radical scavenging activity. The DPPH radical scavenging test was performed as previously described, 9) with slight modifications. The reaction mixture contained 1 ml of 100 mM DPPH in ethanol, 800 ml of Tris-HCl buffer solution (200 mM, pH 7.4) and 200 ml of sample solution in 50% aqueous ethanol. After 20 min at room temperature, the DPPH radical scavenging activity was determined by measuring the absorbance at 517 nm.
Assay for superoxide anion scavenging activity. Superoxide anion radical scavenging activities were estimated by the xanthine oxidase method.
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Isolation of 1. Daedalea dickinsii mycelia were cultured in liquid broth (10 liters) containing glucose (3%), polypeptone (0.5%), yeast extract (0.2%), potassium dihydrogenphosphate (0.1%), and magnesium sulfate heptahydrate (0.05%). After 40 days, the culture broth (dried weight, 50 g) was filtered to give broth and mycelia. The broth was extracted with EtOAc, and the resulting extract (5 g) was chromatographed on silica gel (Wakogel C300, 150 g) with EtOAc/hexane (450 ml each) using a 10% stepwise elution gradient. The 50% EtOAc/hexane eluate (0.85 g) was purified on a silica gel column (Wakogel C300, 160 g) with 30% acetone/ hexane to yield 1 (384 mg). (2R)-2-Hydroxymethyl-6-methoxy-2-methyl-2H-chromene (2) 
